BioSyent Inc. (OTCMKTS:BIOYF) Short Interest Update

BioSyent Inc. (OTCMKTS:BIOYF) was the target of a large drop in short interest in October. As of October 15th, there was short interest totalling 1,100 shares, a drop of 42.1% from the September 30th total of 1,900 shares. Based on an average daily volume of 3,900 shares, the days-to-cover ratio is presently 0.3 days.

BioSyent Trading Up 1.8 %

Shares of OTCMKTS BIOYF traded up $0.14 during midday trading on Friday, hitting $8.21. The stock had a trading volume of 5,216 shares, compared to its average volume of 2,113. The business’s 50 day moving average is $7.92 and its 200-day moving average is $7.25. BioSyent has a 52 week low of $5.65 and a 52 week high of $8.90.

BioSyent Increases Dividend

The business also recently declared a dividend, which was paid on Sunday, September 15th. Stockholders of record on Thursday, September 5th were issued a $0.0334 dividend. The ex-dividend date was Wednesday, September 4th. This is a boost from BioSyent’s previous dividend of $0.03. This represents a dividend yield of 1.72%.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.